Navigation Links
Pfizer Recalls 1 Million Packets of Birth Control Pills
Date:2/1/2012

WEDNESDAY, Feb. 1 (HealthDay News) -- About one million packets of birth control pills are being recalled in the United States by Pfizer Inc. because of a packaging error that could reduce the effectiveness of the pills and cause unintended pregnancies.

The recall of 14 lots of Lo/Ovral-28 tablets and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets was announced late Tuesday after Pfizer discovered that some blister packs may contain either too many or too few active pills and that the pills may be out of sequence. The expiration dates on the recalled packets range between July 31, 2013 and March 31, 2014.

The pills are packaged in blister packs containing 21 active tablets and seven inactive tablets. The packaging error means that the daily regimen for the pills may be incorrect and could leave women without adequate contraception and at risk for unintended pregnancy, Pfizer said in a news release.

Experts said the error could pose real problems for women using the pills.

"This is extremely important," said Dr. Steven Goldstein, professor of obstetrics and gynecology at NYU Langone School of Medicine in New York City. "It is absolutely essential that birth control pills be taken as intended, with 21 medicated pills in a row. Otherwise ovulation could take place and an unintended pregnancy is definitely a possibility."

Another expert agreed.

"Sequence and content of active versus inactive pills is crucial in determining efficacy, including whether or not unwanted pregnancy will be actually prevented," said Dr. Jill Rabin, chief of ambulatory care, obstetrics and gynecology, head of urogynecology at Long Island Jewish Medical Center in New Hyde Park, N.Y.

She said that women who determine that they do have the recalled contraceptive pills should first "ensure that you are not currently pregnant (by taking a pregnancy test) if you have any symptoms of pregnancy (missed periods/abnormal bleeding, etc)." They should also switch immediately to a non-hormonal form of contraception if they are not pregnant, notify their health care provider of the situation, and return the defective product to the pharmacy.

Pfizer has informed the U.S. Food and Drug Administration about the recall. In a statement issued Wednesday, the FDA agreed that "patients who have the affected product should notify their physician and return the product to the pharmacy."

The cause of the error was identified and corrected immediately, according to Pfizer.

The birth control pills were manufactured and packaged by Pfizer and sold under the Akrimax Pharmaceuticals brand. The pills were distributed to warehouses, clinics and retail pharmacies across the United States.

More information

Here's where you can find more details on lot numbers and other information on pills included in the recall.

-- Robert Preidt

SOURCES: Steven Goldstein, M.D., professor, obstetrics and gynecology, NYU Langone School of Medicine, New York City; Jill Rabin, M.D., chief of ambulatory care, obstetrics and gynecology, and head of urogynecology, Long Island Jewish Medical Center, New Hyde Park, N.Y.; Pfizer Inc., news release, Jan. 31, 2012; U.S. Food and Drug Administration, news release, Jan. 31, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UCSF-Pfizer partnership yields projects aimed at clinical trials
2. UCSD Health Sciences partners with Pfizer to speed drug delivery
3. Pfizer Hemophilia presents new data at the World Federation of Hemophilia 2010 Congress
4. Pfizer joins open-access medicinal chemistry public-private collaboration
5. VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia
6. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
7. Report Blames Speedy FDA Clearance for Medical Device Recalls
8. FDA Chief Says More Egg Recalls Possible
9. Drug Maker Recalls More Than 40 Allergy, Cold Meds for Kids
10. Ruiz Foods Recalls 1 Tornados Flavor
11. Herr Foods Inc. Recalls ‘Herr's Cracked Pepper and Sea Salt Flavored' Kettle Style Potato Chips Because of Possible Health Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pfizer Recalls 1 Million Packets of Birth Control Pills
(Date:5/26/2017)... , ... May 26, 2017 , ... Dr. Alex Rabinovich, ... to announce a new, informational blog post on insurance options. If a Bay Area ... plans may help save time and money. Visiting an in-network provider for a second ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the ... Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... to say, he is "panther quick and leather tough." His love for others is ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells the ... of Eden” is the creation of published author, Penelope Colt, mother, trader, horse farmer, artist ... to NYC when she was three. At six, they moved to Dayton, Ohio, where ...
(Date:5/26/2017)... ... May 26, 2017 , ... Water damage to the flooring of several classrooms ... left education officials with a number of critical issues to address before students could ... be accomplished with little or no disruption to class schedules. Second, the project had ...
(Date:5/24/2017)... Ca (PRWEB) , ... May 24, 2017 , ... ... effects and background. Understanind and choosing the most appropriate instruments for research and ... critical in research finding. This webinar will focus on innovations in stereo microscopy ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 2017  Amy Baxter MD, chief executive officer and ... pain relief, was awarded a 2017 Top 40 Healthcare ... recognized at the MM&M Top 40 Healthcare Transformers dinner ... on May 10, 2017. The dinner followed a ... "beyond the pill."  "Innovation goes beyond invention," ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) ... second quarter ended April 1, 2017 .   GAAP ... compared to the prior year period as the sale ... gain, while non-GAAP diluted EPS of $0.50 increased 6.4%.  ... constant currency terms.  Excluding the effects of blood screening ...
(Date:5/10/2017)... Md. , May 10, 2017 CSSi, ... solutions for the clinical research industry, is proud to ... www.CSSiEnroll.com . The new website features both enriched content ... user experience and enhances the company,s already well-established position ... industry. "After many months of hard ...
Breaking Medicine Technology: